|
Posttraumatic Stress Disorder Symptoms May Increase Coronary Heart Disease RiskNews Author: Laurie Barclay, MD Release Date: January 11, 2007; Valid for credit through January 11, 2008
January 11, 2007 — A higher level of symptoms of posttraumatic stress disorder may increase the risk for coronary heart disease in older men, according to the results of the prospective Veterans Affairs Normative Aging Study (NAS) reported in the January issue of the Archives of General Psychiatry. "Various correlates of posttraumatic stress disorder (PTSD), such as high levels of sympathetic activation and hypothalamic-pituitary-adrenal axis dysregulation, have been linked to arterial damage and coronary heart disease (CHD) risk," write Laura D. Kubzansky, PhD, from the Harvard School of Public Health in Boston, Massachusetts, and colleagues. "While psychological disturbance is frequently found among patients with cardiac disease, whether psychological problems precede or occur as a result of having a potentially fatal disease is not clear. To our knowledge, no prospective studies to date have evaluated whether PTSD is associated with increased risk of CHD." The investigators evaluated data provided by community-dwelling men from the Greater Boston, Massachusetts, area who served in the military and who completed either the Mississippi Scale for Combat-Related PTSD in 1990 (n = 1002) or the Minnesota Multiphasic Personality Inventory 2 Keane PTSD (MMPI-1 PK) scale in 1986 (n = 944). Men with preexisting CHD at baseline were excluded, and the primary end point was incident CHD occurring during follow-up through May 2001. In this cohort, levels of PTSD symptoms were low to moderate. For each standard-deviation (SD) increase in symptom level on the Mississippi Scale for Combat-Related PTSD, men had age-adjusted relative risks of 1.26 (95% confidence interval [CI], 1.05 - 1.51) for nonfatal myocardial infarction and fatal CHD combined, and 1.21 (95% CI, 1.05 - 1.41) for all of the CHD outcomes combined (nonfatal myocardial infarction, fatal CHD, and angina). This pattern of results was similar using the MMPI-1 PK scale and somewhat stronger after controlling for levels of depressive symptoms. "To our knowledge, this is the first study to demonstrate a prospective association between PTSD symptoms and CHD even after controlling for depressive symptoms," the authors write. "These results suggest that a higher level of PTSD symptoms may increase the risk of incident CHD in older men." Study limitations include older age of the sample; lack of generalizability to women, nonwhite populations, or civilians; assessment of PTSD symptoms relying on self-report scales; and lack of data on the chronicity and duration of PTSD symptoms or on specific exposure to trauma. "Although an association between PTSD and CHD has often been speculated, much of the evidence to date has been indirect, linking PTSD with coronary risk factors or with neuroendocrine processes known to be related to cardiovascular dysregulation," the authors conclude. "These data suggest that prolonged stress and significant levels of PTSD symptoms may increase the risk for CHD in older male veterans. These results are provocative and suggest that exposure to trauma and prolonged stress not only may increase the risk for serious mental health problems but are also cardiotoxic." The National Institutes of Health, Veterans Affairs Merit Reviews, the National Institute of Mental Health, and the Cooperative Studies Program/Epidemiologic Research and Information Center, Department of Veterans Affairs supported this study in part. The authors have disclosed no relevant financial relationships. Arch Gen Psychiatry. 2007;64:109-116. Clinical ContextPTSD reflects dysregulation of the stress response system, and many studies have shown that CHD and cardiovascular risk factors are more common in people with PTSD. Previously, however, no prospective study has evaluated the association between PTSD and CHD risk to determine whether these conditions share common pathways or whether PTSD itself is a risk factor for CHD. In earlier studies, 29% of an outpatient sample with stable CHD also had PTSD and, compared with controls, men with PTSD had more than twice the risk for atrioventricular conduction defects and infarctions. Other studies, predominantly in veterans, suggest that adverse experiences increase CHD risk, in part because of psychological factors. The biological mechanisms by which PTSD might increase risk for CHD are still unknown, but these most likely involve the neuroendocrinology of PTSD, such as the enhanced negative feedback sensitivity of glucocorticoid receptors in the stress response system; below-normal urinary and plasma cortisol levels; and exaggerated catecholamine responses to trauma-related stimuli. The hemodynamic and/or biochemical processes of catecholamine release can injure the endothelium of coronary arteries and can also enhance release of fatty acids, promoting the development of atherosclerosis. Although evidence to date suggests that prolonged stress promotes the development of CHD, it is less clear whether PTSD has pathophysiological or atherogenic effects. Further compounding the difficulty in analysis is the overlap between symptoms of PTSD and depression. Using the Normative Aging Study (NAS), a community-dwelling cohort of mostly older male veterans, the investigators tested the hypothesis that PTSD symptoms are prospectively associated with CHD, even when controlling for depression. Study Highlights
Pearls for Practice
Medscape Medical News 2007. ©2007 Medscape
Legal Disclaimer
The material presented here does not necessarily reflect the views of
Medscape or companies that support educational programming on
www.medscape.com. These materials may discuss therapeutic products that
have not been approved by the US Food and Drug Administration and
off-label uses of approved products. A qualified healthcare professional
should be consulted before using any therapeutic product discussed.
Readers should verify all information and data before treating patients
or employing any therapies described in this educational activity.
|
|
|
||||||||